Compare RCKT & IIIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCKT | IIIV |
|---|---|---|
| Founded | 1999 | 2012 |
| Country | United States | United States |
| Employees | 202 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 401.6M | 434.2M |
| IPO Year | N/A | 2018 |
| Metric | RCKT | IIIV |
|---|---|---|
| Price | $3.91 | $21.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 5 |
| Target Price | $29.73 | ★ $33.20 |
| AVG Volume (30 Days) | ★ 3.2M | 478.7K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.05 |
| Revenue Next Year | $64.28 | $8.07 |
| P/E Ratio | ★ N/A | $262.38 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.53 | $18.47 |
| 52 Week High | $5.45 | $33.97 |
| Indicator | RCKT | IIIV |
|---|---|---|
| Relative Strength Index (RSI) | 64.16 | 52.52 |
| Support Level | $3.01 | $19.11 |
| Resistance Level | $4.04 | $21.27 |
| Average True Range (ATR) | 0.26 | 0.98 |
| MACD | 0.09 | 0.03 |
| Stochastic Oscillator | 69.32 | 41.69 |
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
i3 Verticals Inc provides mission-critical enterprise software solutions to public sector entities. These comprehensive cloud-native solutions address a broad range of government functions, including courts and public safety, public administration, utilities, transportation and schools. The company generates the majority of revenue from software and related services, including the sale of subscriptions, recurring services, ongoing support, licenses, and installation and implementation services specific to software.